ImmunoCAP ECP Update
We would like to update you with a recent brochure from Thermo Fisher Scientific on the ImmunoCAPTM ECP for quantifying eosinophil cationic protein (ECP).
ImmunoCAPTM ECP measures the level of ECP in serum. A high level of serum ECP indicates inflammation which is a risk factor for asthmatic patients. Measuring ECP in a serum sample is an objective and direct way of estimating the severity of airway inflammation and following the course of disease in asthmatic patients.
Clinical importance in asthma
ImmunoCAPTM ECP serum measurements can be used:
- To monitor inflammation in asthma
- To guide corticosteroid treatment in asthma
- To find non-compliant patients
ImmunoCAPTM ECP helps to identify ongoing inflammation associated with asthma and aids in determining appropriate therapy for asthmatic patients.